Arkos Global Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,962
Closed -$249K 137
2026
Q1
$249K Hold
3,962
0.03% 107
2025
Q4
$378K Sell
3,962
-5,402
-58% -$530K 0.05% 85
2025
Q3
$914K Buy
9,364
+3,341
+55% +$346K 0.12% 50
2025
Q2
$647K Hold
6,023
0.09% 58
2025
Q1
$608K Hold
6,023
0.09% 61
2024
Q4
$538K Sell
6,023
-351
-6% -$30.9K 0.08% 67
2024
Q3
$534K Buy
6,374
+30
+0.5% +$2.37K 0.08% 65
2024
Q2
$489K Hold
6,344
0.08% 67
2024
Q1
$435K Hold
6,344
0.07% 77
2023
Q4
$367K Sell
6,344
-454
-7% -$24.2K 0.07% 71
2023
Q3
$359K Hold
6,798
0.07% 65
2023
Q2
$368K Sell
6,798
-500
-7% -$26.1K 0.07% 63
2023
Q1
$365K Hold
7,298
0.07% 63
2022
Q4
$338K Sell
7,298
-1,000
-12% -$43.3K 0.09% 66
2022
Q3
$321K Sell
8,298
-4,180
-33% -$168K 0.1% 58
2022
Q2
$465K Buy
12,478
+1,625
+15% +$66.1K 0.13% 45
2022
Q1
$481K Hold
10,853
0.13% 48
2021
Q4
$461K Sell
10,853
-500
-4% -$21K 0.14% 51
2021
Q3
$493K Hold
11,353
0.17% 40
2021
Q2
$485K Hold
11,353
0.17% 43
2021
Q1
$439K Hold
11,353
0.17% 45
2020
Q4
$408K Hold
11,353
0.17% 46
2020
Q3
$434K Sell
11,353
-114
-1% -$4.39K 0.2% 42
2020
Q2
$403K Hold
11,467
0.21% 51
2020
Q1
$374K Buy
+11,467
New +$448K 0.25% 45

Other funds holding BSX

Arkos Global Advisors's BSX Position: Q2 2026 in Review

Arkos Global Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,962 shares — an estimated $249K sold.

Arkos Global Advisors first reported a position in BSX in Q1 2020 and held it in 25 quarters. The position peaked at $914K in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Arkos Global Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Arkos Global Advisors sold 3,962 Boston Scientific shares in Q2 2026, an estimated $249K.
  • Arkos Global Advisors first reported a position in Boston Scientific in Q1 2020 and held it in 25 quarters.
  • Arkos Global Advisors's Boston Scientific position peaked at $914K in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.